{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:15:43Z","timestamp":1793888143722,"version":"4.8.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Breast cancer, a highly heterogeneous malignancy and a leading cause of cancer-related mortality among women worldwide, is profoundly shaped in its initiation, progression, and therapeutic response by the tumor immune microenvironment (TIME). This review consolidates recent advances in deciphering the cellular, molecular, and metabolic complexity of breast cancer TIME and highlights mechanisms of immune suppression that impede durable treatment efficacy. We critically appraise current and emerging immunotherapeutic approaches, with a focus on strategies that aim to transform immunologically \u201ccold\u201d tumors into \u201chot,\u201d immune-responsive phenotypes. Novel directions, including metabolic modulation, stromal reprogramming, and precision combination therapies, are discussed in the context of overcoming primary and acquired resistance. We highlight emerging biomarker strategies that integrate spatial transcriptomics to map immune exclusion zones, along with liquid biopsy monitoring of exosomal PD-L1 and circulating tumor DNA, to enable real-time adaptation of combination immunotherapy regimens.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1760782","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:38:34Z","timestamp":1770964714000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Chang","family":"Ma","sequence":"first","affiliation":[{"name":"School of Public Health, Jilin Medical University","place":["Jilin, Jilin, China"]},{"name":"Department of Preclinical Sciences, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman","place":["Kajang, Selangor, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon Koon","family":"Teoh","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman","place":["Kajang, Selangor, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, No. 965 Hospital of People's Liberation Army Joint Logistics Support Force","place":["Jilin, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[{"name":"Brain Science Institute, Jilin Medical University","place":["Jilin, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Brain Science Institute, Jilin Medical University","place":["Jilin, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health, Jilin Medical University","place":["Jilin, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Public Health, Jilin Medical University","place":["Jilin, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooi Tin","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman","place":["Kajang, Selangor, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B3","article-title":"Breast cancer treatment","volume":"104","author":"Trayes","year":"2021","journal-title":"Am Fam Physician"},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S336643","article-title":"The role of progesterone receptors in breast cancer","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1457491","article-title":"Reprogramming the tumor microenvironment - macrophages emerge as key players in breast cancer immunotherapy","volume":"15","author":"Sami","year":"2024","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13058-024-01887-6","article-title":"Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer","volume":"26","author":"Zhang","year":"2024","journal-title":"Breast Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02202-9","article-title":"Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance","volume":"24","author":"Mai","year":"2025","journal-title":"Mol Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32030143","article-title":"Breast cancer and tumor microenvironment: the crucial role of immune cells","volume":"32","author":"Moura","year":"2025","journal-title":"Curr Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-025-09202-9","article-title":"Rescuing dendritic cell interstitial motility sustains antitumour immunity","author":"Tang","year":"2025","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117714","article-title":"Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers","volume":"181","author":"Yuan","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062795","article-title":"Intra-tumoral sphingobacterium multivorum promotes triple-negativebreast cancer progression by suppressing tumor immunosurveillance","volume":"26","author":"Niture","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0373-7","article-title":"Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms","volume":"21","author":"Kim","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","article-title":"PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0402","article-title":"Pharmacologic suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers","volume":"10","author":"Song","year":"2020","journal-title":"Cancer Discov"},{"key":"B20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13046-024-03218-1","article-title":"Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer","volume":"43","author":"Mussa","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032969","article-title":"Triple-negative breast cancer and predictive markers of response to neoadjuvant chemotherapy: A systematic review","volume":"24","author":"van den Ende","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.3056","article-title":"Tumor-infiltrating lymphocytes in triple-negative breast cancer","volume":"331","author":"Leon-Ferre","year":"2024","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105866","article-title":"Tumor infiltrating lymphocytes in breast cancer: A narrative review with focus on analytic validity, clinical validity, and clinical utility","volume":"162","author":"Finkelman","year":"2025","journal-title":"Hum Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","article-title":"Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy","volume":"18","author":"Hu","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40364-025-00757-3","article-title":"Extracellular matrix: unlocking new avenues in cancer treatment","volume":"13","author":"Lee","year":"2025","journal-title":"biomark Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05771-7","article-title":"Tumor-infiltrating lymphocytes (TILs) in ER+\/HER2- breast cancer","volume":"183","author":"Criscitiello","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06291-y","article-title":"New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy","volume":"23","author":"Lin","year":"2025","journal-title":"J Trans Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Mary Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102397","article-title":"AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity","volume":"85","author":"Schnoegl","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"eabo4094","DOI":"10.1126\/scisignal.abo4094","article-title":"IKK promotes na\u00efve T cell survival by repressing RIPK1-dependent apoptosis and activating NF-\u03baB","volume":"16","author":"Carty","year":"2023","journal-title":"Sci Signal"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.083","article-title":"I\u03baB kinase \u03f5 Is an NFATc1 kinase that inhibits T cell immune response","volume":"16","author":"Zhang","year":"2016","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2024.0436","article-title":"PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer","volume":"21","author":"Qiu","year":"2024","journal-title":"Cancer Biol Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","article-title":"Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-\u03b2 type II receptor signaling","volume":"13","author":"Xie","year":"2022","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.990419","article-title":"TOX regulates T lymphocytes differentiation and its function in tumor","volume":"14","author":"Niu","year":"2023","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/jrf.0.0760375","article-title":"Use of progesterone 11-glucuronide-alkaline phosphatase conjugate in a sensitive microtitre-plate enzymeimmunoassay of progesterone in milk and its application to pregnancy testing in dairy cattle","volume":"76","author":"Sauer","year":"1986","journal-title":"J Reprod Fertil"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1118346","article-title":"Characteristics and postoperative dynamic changes in circulating CD4+ helper T lymphocytes in patients with breast cancer","volume":"13","author":"Lu","year":"2023","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04439-0","article-title":"A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells","volume":"603","author":"Seung","year":"2022","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106087","article-title":"Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target","volume":"78","author":"Hashemi","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac123","article-title":"Treg specialization and functions beyond immune suppression","volume":"211","author":"Astarita","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e2300895120","DOI":"10.1073\/pnas.2300895120","article-title":"Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies","volume":"120","author":"Lax","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117430","article-title":"Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer","volume":"179","author":"Ni","year":"2024","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural Killer cells at the frontline in the fight against cancer","volume":"15","author":"Co\u00ebnon","year":"2024","journal-title":"Cell Death Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-025-08021-0","article-title":"Combined IFN-\u03b3 and TNF-\u03b1 treatment enhances the susceptibility of breast cancer cells and spheroids to natural killer cell-mediated killing","volume":"16","author":"Barberini","year":"2025","journal-title":"Cell Death Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13058-025-01964-4","article-title":"Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers","volume":"27","author":"Ehlers","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12658","article-title":"Advances in natural killer cell therapies for breast cancer","volume":"101","author":"Kiaei","year":"2023","journal-title":"Immunol Cell Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1420205","article-title":"The basic biology of NK cells and its application in tumor immunotherapy","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106932","article-title":"NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances","volume":"270","author":"Greppi","year":"2024","journal-title":"Immunol Lett"},{"key":"B52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-infiltrating natural killer cells","volume":"11","author":"C\u00f3zar","year":"2021","journal-title":"Cancer Discov"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082226","article-title":"Understanding the role of innate immune cells and identifying genes in breast cancer microenvironment","volume":"12","author":"Shihab","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886045","article-title":"Role of ILC2s in solid tumors: facilitate or inhibit","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nm0598-627","article-title":"B cells inhibit induction of T cell-dependent tumor immunity","volume":"4","author":"Qin","year":"1998","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051517","article-title":"B cells in breast cancer pathology","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1002\/mco2.343","article-title":"Hot and cold tumors: Immunological features and the therapeutic strategies","volume":"4","author":"Wang","year":"2023","journal-title":"MedComm (2020)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2024.33008","article-title":"The tumor immune microenvironment in breast cancer progression","volume":"63","author":"Otterlei Fj\u00f8rtoft","year":"2024","journal-title":"Acta Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13058-023-01717-1","article-title":"B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer","volume":"25","author":"Steenbruggen","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41467-025-56279-x","article-title":"Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers","volume":"16","author":"Griffiths","year":"2025","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612890","article-title":"CXCR4 expressed by tumor-infiltrating B cells in gastric cancer related to survival in the tumor microenvironment: an analysis combining single-cell RNA sequencing with bulk RNA sequencing","volume":"24","author":"Su","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117436","article-title":"Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment","volume":"179","author":"Xue","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3578","article-title":"Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF","volume":"19","author":"Quail","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800556","article-title":"Innate T cells govern adipose tissue biology","volume":"201","author":"LaMarche","year":"2018","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13050987","article-title":"Cancer-associated fibroblasts as a common orchestrator of therapy resistance in lung and pancreatic cancer","volume":"13","author":"Domen","year":"2021","journal-title":"Cancers"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152484","article-title":"Cancer-associated fibroblasts: immunosuppressive crosstalk with tumor-infiltrating immune cells and implications for therapeutic resistance","volume":"17","author":"Pawar","year":"2025","journal-title":"Cancers"},{"key":"B71","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-025-03527-z","article-title":"Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"115432","DOI":"10.1016\/j.celrep.2025.115432","article-title":"The tumor microenvironment is an ecosystem sustained by metabolic interactions","volume":"44","author":"Kay","year":"2025","journal-title":"Cell Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/cells14171398","article-title":"Cancer-associated fibroblasts in solid tumors and sarcomas: heterogeneity, function, and therapeutic implications","volume":"14","author":"Badran","year":"2025","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1038\/s41467-024-53908-9","article-title":"Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer Malignancy","volume":"15","author":"Forsthuber","year":"2024","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1063051","article-title":"Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point","volume":"13","author":"Thomas","year":"2023","journal-title":"Front Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10238-024-01501-1","article-title":"Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies","volume":"24","author":"Ciep\u0142a","year":"2024","journal-title":"Clin Exp Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.11.058","article-title":"Dual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatment","volume":"377","author":"Qi","year":"2025","journal-title":"J Control Release"},{"key":"B78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-025-01731-0","article-title":"Target neutrophil heterogeneity and plasticity in cancer","volume":"18","author":"Feng","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-22-0115","article-title":"Secreted Fas decoys enhance the antitumor activity of engineered and bystander T cells in Fas ligand\u2013expressing solid tumors","volume":"10","author":"Bajgain","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molimm.2019.01.014","article-title":"Fas\/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response","volume":"107","author":"Yajima","year":"2019","journal-title":"Mol Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/2326-6066.CIR-23-0037","article-title":"Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer","volume":"12","author":"Yan","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1038\/s41467-025-64047-0","article-title":"Artery formation in the intestinal wall and mesentery by intestine-derived Esm1+ endothelial cells","volume":"16","author":"Bovay","year":"2025","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1589841","article-title":"Bevacizumab in ovarian cancer therapy: current advances, clinical challenges, and emerging strategies","volume":"13","author":"Zhang","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s42003-020-0837-0","article-title":"Single-cell RNA sequencing reveals a heterogeneous response to Glucocorticoids in breast cancer cells","volume":"3","author":"Hoffman","year":"2020","journal-title":"Commun Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1521388","article-title":"Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions","volume":"16","author":"Xin","year":"2025","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2024.5684","article-title":"Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)","volume":"65","author":"Liu","year":"2024","journal-title":"Int J Oncol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01304-w","article-title":"Targeting metabolism to enhance immunotherapy within tumor microenvironment","volume":"45","author":"Liang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.02.008","article-title":"Lactate: A key regulator of the immune response","volume":"58","author":"Llibre","year":"2025","journal-title":"Immunity"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610303","article-title":"The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy","volume":"11","author":"Salemme","year":"2021","journal-title":"Front Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123810","article-title":"Lactate induces tumor-associated macrophage polarization independent of mitochondrial pyruvate carrier-mediated metabolism","volume":"237","author":"Fang","year":"2023","journal-title":"Int J Biol Macromolecules"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.010","article-title":"Lactate induces production of the tRNAHis half to promote B-lymphoblastic cell proliferation","volume":"28","author":"Mo","year":"2020","journal-title":"Mol Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133390","article-title":"Role of glucose metabolic reprogramming in breast cancer progression and drug resistance","volume":"15","author":"Lei","year":"2023","journal-title":"Cancers"},{"key":"B96","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-025-10956-y","article-title":"Metabolic plasticity and cancer stem cell metabolism: exploring the glycolysis-OXPHOS switch as a mechanism for resistance and tumorigenesis","volume":"21","author":"Keoh","year":"2025","journal-title":"Stem Cell Rev Rep"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2018.05.001","article-title":"Targeting the CD73-adenosine axis in immuno-oncology","volume":"205","author":"Allard","year":"2019","journal-title":"Immunol Lett"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02151","article-title":"Development of CD73 inhibitors in tumor immunotherapy and opportunities in imaging and combination therapy","volume":"68","author":"Bi","year":"2025","journal-title":"J Med Chem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41420-024-02006-2","article-title":"Immunometabolism in cancer: basic mechanisms and new targeting strategy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Discov"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189166","article-title":"Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy","volume":"1879","author":"Jia","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41420-025-02468-y","article-title":"Metabolic reprogramming in T cell senescence: a novel strategy for cancer immunotherapy","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561388","article-title":"Single-cell and spatial transcriptomic insights into glioma cellular heterogeneity and metabolic adaptations","volume":"16","author":"Fu","year":"2025","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1038\/s41467-025-59878-w","article-title":"Dynamic single-cell metabolomics reveals cell-cell interaction between tumor cells and macrophages","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.830208","article-title":"Key players of the immunosuppressive tumor microenvironment and emerging therapeutic strategies","volume":"10","author":"Park","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1630464","article-title":"Immunotherapy resistance in triple-negative breast cancer: Molecular mechanisms, tumor microenvironment, and therapeutic implications","volume":"15","author":"Zhou","year":"2025","journal-title":"Front Oncol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","article-title":"Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy","volume":"16","author":"Cai","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","article-title":"TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives","volume":"6","author":"Yan","year":"2025","journal-title":"Mol BioMed"},{"key":"B111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40364-023-00543-z","article-title":"Targeting TIGIT for cancer immunotherapy: recent advances and future directions","volume":"12","author":"Zhang","year":"2024","journal-title":"biomark Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41419-025-07984-4","article-title":"TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies","volume":"16","author":"Cui","year":"2025","journal-title":"Cell Death Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032943","article-title":"The evolution of single-cell RNA sequencing technology and application: progress and perspectives","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"B115","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00262-025-04086-0","article-title":"High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer","volume":"74","author":"Dutta","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-022-00160-w","article-title":"A comprehensive profile of TCF1+ progenitor and TCF1\u2013 terminally exhausted PD-1+CD8+ T cells in head and neck squamous cell carcinoma: implications for prognosis and immunotherapy","volume":"14","author":"Wang","year":"2022","journal-title":"Int J Oral Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-025-01051-y","article-title":"Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy","volume":"48","author":"Toghraie","year":"2025","journal-title":"Cell Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1582532","article-title":"Revisiting the role of cancer-associated fibroblasts in tumor microenvironment","volume":"16","author":"Lan","year":"2025","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671595","article-title":"Cancer-associated fibroblast heterogeneity: A factor that cannot be ignored in immune microenvironment remodeling","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate immunosuppression and drive breast cancer progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105606","article-title":"Targeting CXCL12-CXCR4 signaling enhances immune checkpoint blockade therapy against triple negative breast cancer","volume":"157","author":"Lu","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"598","DOI":"10.37349\/etat.2022.00103","article-title":"Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions","volume":"3","author":"Thiery","year":"2022","journal-title":"Explor Target Antitumor Ther"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061519","article-title":"B\u00eate noire of chemotherapy and targeted therapy: CAF-mediated resistance","volume":"14","author":"De","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1084\/jem.20171818","article-title":"Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer","volume":"215","author":"Shee","year":"2018","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1635771","article-title":"Cancer-associated fibroblasts: dual roles from senescence sentinels to death regulators and new dimensions in therapy","volume":"16","author":"Ruan","year":"2025","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561577","article-title":"Benign non-immune cells in tumor microenvironment","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.752818","article-title":"Tumor-derived exosomes modulate primary site tumor metastasis","volume":"10","author":"Bai","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.11.050","article-title":"Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche","volume":"353","author":"Luo","year":"2023","journal-title":"J Control Release"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2024.02.05","article-title":"New roles of tumor-derived exosomes in tumor microenvironment","volume":"36","author":"Chen","year":"2024","journal-title":"Chin J Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0295-2","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00262-025-04047-7","article-title":"Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages","volume":"74","author":"Yuan","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B133","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-021-01492-7","article-title":"Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy","volume":"21","author":"Hosseini","year":"2022","journal-title":"Mol Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1006429","article-title":"Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s42003-023-05169-3","article-title":"Small EV in plasma of triple negative breast cancer patients induce intrinsic apoptosis in activated T cells","volume":"6","author":"Mondal","year":"2023","journal-title":"Commun Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.569219","article-title":"Exosomal PD-L1: new insights into tumor immune escape mechanisms and therapeutic strategies","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26072923","article-title":"Immune modulation and immunotherapy in solid tumors: mechanisms of resistance and potential therapeutic strategies","volume":"26","author":"Giri","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106532","article-title":"Gram-negative intratumoral bacteria mediate lymph node metastasis through LPS-TLR4\/MAPK signaling pathway in cervical cancer","volume":"91","author":"Liu","year":"2025","journal-title":"J Infect"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14060526","article-title":"Generation of immune modulating small metabolites-metabokines-by adult schistosomes","volume":"14","author":"Skelly","year":"2025","journal-title":"Pathogens"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1001956","article-title":"Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)","volume":"13","author":"Ogbechi","year":"2022","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","article-title":"Molecular mimicry as a mechanism of viral immune evasion and autoimmunity","volume":"15","author":"Maguire","year":"2024","journal-title":"Nat Commun"},{"key":"B144","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-024-03004-z","article-title":"Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)","volume":"43","author":"Cavalluzzo","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1465889","article-title":"Mechanisms governing bystander activation of T cells","volume":"15","author":"Yosri","year":"2024","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01190-2","article-title":"Diagnostic biopsy does not accurately reflect the PD-L1 expression in triple-negative breast cancer","volume":"23","author":"Zdrenka","year":"2023","journal-title":"Clin Exp Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0563-2","article-title":"Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer","volume":"18","author":"Liang","year":"2020","journal-title":"J Nanobiotechnology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1021\/acsnano.2c10219","article-title":"Immune exosomes loading self-assembled nanomicelles traverse the blood-brain barrier for chemo-immunotherapy against glioblastoma","author":"Cui","year":"2023","journal-title":"ACS Nano"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40168-019-0774-7","article-title":"Mobile resistome of human gut and pathogen drives anthropogenic bloom of antibiotic resistance","volume":"8","author":"Lee","year":"2020","journal-title":"Microbiome"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-090222-102035","article-title":"Microbial metabolites and gut immunology","volume":"42","author":"Takeuchi","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e191595","DOI":"10.1172\/jci.insight.191595","article-title":"Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia","volume":"10","author":"Lyman","year":"2025","journal-title":"JCI Insight"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-025-02795-z","article-title":"Spatial gene expression at single-cell resolution from histology using deep learning with GHIST","volume":"22","author":"Fu","year":"2025","journal-title":"Nat Methods"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943253","article-title":"Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis","volume":"12","author":"S\u00e1nchez-Herrero","year":"2022","journal-title":"Front Oncol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e48320","DOI":"10.2196\/48320","article-title":"The use of deep learning and machine learning on longitudinal electronic health records for the early detection and prevention of diseases: scoping review","volume":"26","author":"Swinckels","year":"2024","journal-title":"J Med Internet Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12935-025-03806-x","article-title":"Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects","volume":"25","author":"Lu","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00793-2","article-title":"A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics","volume":"5","author":"Hoang","year":"2024","journal-title":"Nat Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01560-y","article-title":"Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretab le multimodal deep learning","volume":"8","author":"Bai","year":"2025","journal-title":"NPJ Digit. Med"},{"key":"B158","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13062-025-00661-8","article-title":"Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review","volume":"20","author":"Krasniqi","year":"2025","journal-title":"Biol Direct"},{"key":"B159","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12916-023-03017-z","article-title":"Potential value of ctDNA monitoring in metastatic HR\u2009+\u2009\/HER2\u2009\u2013\u2009breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial","volume":"21","author":"Chiu","year":"2023","journal-title":"BMC Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41698-025-01084-4","article-title":"Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent\/metastatic head and neck cancer","volume":"9","author":"Ruiz-Torres","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100947","article-title":"PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity","volume":"68","author":"Du","year":"2023","journal-title":"Drug Resist Update"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30812-X","article-title":"Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial","volume":"20","author":"Loi","year":"2019","journal-title":"Lancet Oncol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1547025","article-title":"mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy","volume":"13","author":"Haghmorad","year":"2025","journal-title":"Front Bioeng. Biotechnol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115625","article-title":"Organ-specificity of breast cancer metastasis","volume":"24","author":"Ibragimova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B168","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/s41467-022-32430-w","article-title":"Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma","volume":"13","author":"Coy","year":"2022","journal-title":"Nat Commun"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.124605","article-title":"A non-destructive X-ray fluorescence method of analysis of formalin fixed-paraffin embedded biopsied samples for biomarkers for breast and colon cancer","volume":"260","author":"Pessanha","year":"2023","journal-title":"Talanta"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2057396","article-title":"Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes","volume":"11","author":"Rethacker","year":"2022","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1760782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:28:35Z","timestamp":1771928915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1760782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":170,"alternative-id":["10.3389\/fimmu.2026.1760782"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1760782","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"article-number":"1760782"}}